Metropolis Healthcare has received approval from board of directors for acquisition of the balance Equity stake of 35% i.e. 10,50,000 Equity shares of Rs 10 each in Metropolis Histoxpert Digital Services (Histoxpert). The Board of Directors at their meeting held on August 06, 2021 has approved the same.
Metropolis Healthcare offers a comprehensive range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
